{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:22:25Z","timestamp":1791660145993,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>During the coronavirus disease 2019 (COVID-19) pandemic in the Netherlands it was noticed that very few blood cultures from COVID-19 patients turned positive with clinically relevant bacteria. This was particularly evident in comparison to the number of positive blood cultures during previous seasonal epidemics of influenza. This observation raised questions about the occurrence and causative microorganisms of bacteraemia in COVID-19 patients, especially in the perspective of the widely reported overuse of antibiotics and the rising rate of antibiotic resistance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective cohort study on blood culture results in influenza A, influenza B and COVID-19 patients presenting to two hospitals in the Netherlands. Our main outcome consisted of the percentage of positive blood cultures. The percentage of clinically relevant blood cultures, isolated bacteria and 30-day all-cause mortality served as our secondary outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1331 viral episodes were analysed in 1324 patients. There was no statistically significant difference (<jats:italic>p<\/jats:italic>\u2009=\u20090.47) in overall occurrence of blood culture positivity in COVID-19 patients (9.0, 95% CI 6.8\u201311.1) in comparison to influenza A (11.4, 95% CI 7.9\u201314.8) and influenza B patients (10.4, 95% CI 7.1\u201313.7,). After correcting for the high rate of contamination, the occurrence of clinically relevant bacteraemia in COVID-19 patients amounted to 1.0% (95% CI 0.3\u20131.8), which was statistically significantly lower (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) compared to influenza A patients (4.0, 95% CI 1.9\u20136.1) and influenza B patients (3.0, 95% CI 1.2\u20134.9). The most frequently identified bacterial isolates in COVID-19 patients were <jats:italic>Escherichia coli<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2009=\u20092) and <jats:italic>Streptococcus pneumoniae<\/jats:italic> (n\u2009=\u20092). The overall 30-day all-cause mortality for COVID-19 patients was 28.3% (95% CI 24.9\u201331.7), which was statistically significantly higher (p\u2009=\u2009&lt;.001) when compared to patients with influenza A (7.1, 95% CI 4.3\u20139.9) and patients with influenza B (6.4, 95% CI 3.8\u20139.1).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We report a very low occurrence of community-acquired bacteraemia amongst COVID-19 patients in comparison to influenza patients. These results reinforce current clinical guidelines on antibiotic management in COVID-19, which only advise utilization of antibiotics when a bacterial co-infection is suspected.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-05902-5","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T09:04:07Z","timestamp":1613984647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Community-acquired bacteraemia in COVID-19 in comparison to influenza A and influenza B: a retrospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Julinha M.","family":"Thelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G. ( Noud)","family":"Buenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"van Apeldoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiman F.","family":"Wertheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam H. A.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"issue":"13","key":"5902_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199\u2013207. https:\/\/doi.org\/10.1056\/NEJMoa2001316.","journal-title":"N Engl J Med"},{"issue":"4","key":"5902_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/jmv.25678","volume":"92","author":"H Lu","year":"2020","unstructured":"Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020 Apr;92(4):401\u20132. https:\/\/doi.org\/10.1002\/jmv.25678.","journal-title":"J Med Virol"},{"key":"5902_CR3","first-page":"D496","volume":"164","author":"CEA Alderweireld","year":"2020","unstructured":"Alderweireld CEA, Buiting AGM, Murk JLAN, Verweij JJ, Berrevoets MAH, van Kasteren MEE. COVID-19: pati\u00ebnt nul in Nederland. Ned Tijdschr Geneeskd. 2020;164:D496 Only published online.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"3","key":"5902_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2012.194139","volume":"309","author":"DS Chertow","year":"2013","unstructured":"Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309(3):275\u201382. https:\/\/doi.org\/10.1001\/jama.2012.194139 PMID: 23321766.","journal-title":"JAMA"},{"issue":"2","key":"5902_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","volume":"289","author":"WW Thompson","year":"2003","unstructured":"Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179\u201386. https:\/\/doi.org\/10.1001\/jama.289.2.179.","journal-title":"JAMA."},{"issue":"5","key":"5902_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/irv.12398","volume":"10","author":"EY Klein","year":"2016","unstructured":"Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016;10(5):394\u2013403. https:\/\/doi.org\/10.1111\/irv.12398.","journal-title":"Influenza Other Respir Viruses"},{"key":"5902_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","volume":"8","author":"DE Morris","year":"2017","unstructured":"Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8:1041. https:\/\/doi.org\/10.3389\/fmicb.2017.01041.","journal-title":"Front Microbiol"},{"key":"5902_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2471\/BLT.20.268573","volume":"98","author":"H Getahun","year":"2020","unstructured":"Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Orgn. 2020;98:442\u2013442A. https:\/\/doi.org\/10.2471\/BLT.20.268573.","journal-title":"Bull World Health Orgn"},{"issue":"20","key":"5902_CR9","doi-asserted-by":"publisher","first-page":"30594","DOI":"10.1016\/j.cmi.2020.09.041","volume":"S1198-743X","author":"E Sieswerda","year":"2020","unstructured":"Sieswerda E, de Boer MGJ, Bonten MMJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, van de Garde EMW, Verheij TJ, van der Eerden MM, Prins JM, Wiersinga WJ. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clin Microbiol Infect. 2020;S1198-743X(20):30594\u20132. https:\/\/doi.org\/10.1016\/j.cmi.2020.09.041 Epub ahead of print. PMID: 33010444; PMCID: PMC7527308.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"5902_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.7326\/0003-4819-134-6-200103200-00013","volume":"134","author":"R Gonzales","year":"2001","unstructured":"Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001;134(6):479\u201386. https:\/\/doi.org\/10.7326\/0003-4819-134-6-200103200-00013.","journal-title":"Ann Intern Med"},{"issue":"3","key":"5902_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.annemergmed.2007.03.022","volume":"50","author":"JP Metlay","year":"2007","unstructured":"Metlay JP, Camargo CA Jr, MacKenzie T, et al. Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments. Ann Emerg Med. 2007;50(3):221\u201330. https:\/\/doi.org\/10.1016\/j.annemergmed.2007.03.022.","journal-title":"Ann Emerg Med"},{"key":"5902_CR12","first-page":"D500","volume":"164","author":"AG Buenen","year":"2020","unstructured":"Buenen AG, Wever PC, Borst DP, Slieker KA. COVID-19 op de Spoedeisende hulp in Bernhoven. Ned Tijdschr Geneeskd. 2020;164:D500 Only published online.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"5902_CR13","doi-asserted-by":"publisher","unstructured":"Karami Z, Knoop BT, Dofferhoff ASM, Blaauw MJT, Janssen NA, van Apeldoorn M, Kerckhoffs APM, van de Maat JS, Hoogerwerf JJ, Ten Oever J. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis (Lond). 2020:1\u20139. https:\/\/doi.org\/10.1080\/23744235.2020.1839672 Epub ahead of print. PMID: 33103530.","DOI":"10.1080\/23744235.2020.1839672"},{"issue":"10229","key":"5902_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet."},{"key":"5902_CR15","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/IDR.S173867","volume":"11","author":"B Aslam","year":"2018","unstructured":"Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645\u201358. https:\/\/doi.org\/10.2147\/IDR.S173867.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"5902_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/CMR.00062-05","volume":"19","author":"KK Hall","year":"2006","unstructured":"Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev. 2006;19(4):788\u2013802. https:\/\/doi.org\/10.1128\/CMR.00062-05.","journal-title":"Clin Microbiol Rev"},{"key":"5902_CR17","doi-asserted-by":"publisher","unstructured":"Sepulveda J, Westblade LF, Whittier S, et al. Bacteremia and blood culture utilization during COVID-19 surge in New York City. J Clin Microbiol. 2020. https:\/\/doi.org\/10.1128\/JCM.00875-20.","DOI":"10.1128\/JCM.00875-20"},{"key":"5902_CR18","doi-asserted-by":"publisher","unstructured":"Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;S1198-743X(20)30369\u20134. doi:https:\/\/doi.org\/10.1016\/j.cmi.2020.06.025","DOI":"10.1016\/j.cmi.2020.06.025"},{"issue":"24","key":"5902_CR19","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","volume":"382","author":"P Goyal","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372\u20134. https:\/\/doi.org\/10.1056\/NEJMc2010419.","journal-title":"N Engl J Med"},{"key":"5902_CR20","doi-asserted-by":"publisher","unstructured":"Nersesjan V, Amiri M, Christensen HK, Benros ME, Kondziella D. 30-day mortality and morbidity in COVID-19 versus influenza: A population based study. medRxiv 2020.07.25.20162156; doi: https:\/\/doi.org\/10.1101\/2020.07.25.20162156.","DOI":"10.1101\/2020.07.25.20162156"},{"key":"5902_CR21","doi-asserted-by":"publisher","first-page":"104931","DOI":"10.1016\/j.phrs.2020.104931","volume":"158","author":"A Giacomelli","year":"2020","unstructured":"Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, Bonazzetti C, Covizzi A, Schiuma M, Passerini M, Piscaglia M, Coen M, Gubertini G, Rizzardini G, Cogliati C, Brambilla AM, Colombo R, Castelli A, Rech R, Riva A, Torre A, Meroni L, Rusconi S, Antinori S, Galli M. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020;158:104931. https:\/\/doi.org\/10.1016\/j.phrs.2020.104931 Epub 2020 May 22. PMID: 32446978; PMCID: PMC7242199.","journal-title":"Pharmacol Res"},{"issue":"3","key":"5902_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2012.04.009","volume":"65","author":"C Cill\u00f3niz","year":"2012","unstructured":"Cill\u00f3niz C, Ewig S, Men\u00e9ndez R, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Inf Secur. 2012;65(3):223\u201330. https:\/\/doi.org\/10.1016\/j.jinf.2012.04.009.","journal-title":"J Inf Secur"},{"issue":"2","key":"5902_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jiac.2018.10.014","volume":"25","author":"F Teng","year":"2019","unstructured":"Teng F, Liu X, Guo SB, et al. Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients. J Infect Chemother. 2019;25(2):129\u201336. https:\/\/doi.org\/10.1016\/j.jiac.2018.10.014.","journal-title":"J Infect Chemother"},{"key":"5902_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1471-2334-10-308","volume":"10","author":"T Aebi","year":"2010","unstructured":"Aebi T, Weisser M, Bucher E, Hirsch HH, Marsch S, Siegemund M. Co-infection of Influenza B and Streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect Dis. 2010;10:308. Published 2010 Oct 27. https:\/\/doi.org\/10.1186\/1471-2334-10-308.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5902_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/s0036-46652008000100009","volume":"50","author":"DA Mancini","year":"2008","unstructured":"Mancini DA, Alves RC, Mendon\u00e7a RM, et al. Influenza virus and proteolytic bacteria co-infection in respiratory tract from individuals presenting respiratory manifestations. Rev Inst Med Trop Sao Paulo. 2008;50(1):41\u20136. https:\/\/doi.org\/10.1590\/s0036-46652008000100009.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"5","key":"5902_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1183\/09031936.00037410","volume":"37","author":"H von Baum","year":"2011","unstructured":"von Baum H, Schweiger B, Welte T, Marre R, Suttorp N, Pletz MWR, Ewig S. How deadly is seasonal influenza-associated pneumonia? The German competence network for community-acquired pneumonia. Eur Respir J. 2011;37(5):1151\u20137. https:\/\/doi.org\/10.1183\/09031936.00037410.","journal-title":"Eur Respir J"},{"issue":"3","key":"5902_CR27","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.Let.20.3.3","volume":"20","author":"J Han","year":"2020","unstructured":"Han J, Gatheral T, Williams C. Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19. Clin Med (Lond). 2020;20(3):e47 doi:10.7861\/clinmed. Let.20.3.3.","journal-title":"Clin Med (Lond)"},{"issue":"10223","key":"5902_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet."},{"key":"5902_CR29","doi-asserted-by":"publisher","unstructured":"Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;ciaa530. https:\/\/doi.org\/10.1093\/cid\/ciaa530.","DOI":"10.1093\/cid\/ciaa530"},{"issue":"15","key":"5902_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciaa272","volume":"71","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):769\u201377. https:\/\/doi.org\/10.1093\/cid\/ciaa272.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05902-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-021-05902-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05902-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T09:07:16Z","timestamp":1613984836000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-05902-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5902"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-05902-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The scientific review boards of both the Jeroen Bosch Hospital and Bernhoven Hospital approved this study. Ethical approval was granted by the Medical Ethical Committee Brabant. Due to the collected data being held anonymously, informed consent was waived. This was in line with the regulations of the hospital boards of both the Jeroen Bosch Hospital and Bernhoven Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}